“…Its incidence is increasing in the United States and the rest of the world, but there is currently no effective drug therapy (2,3). While the 1 Division of Gastroenterology, Hepatology and Nutrition, Ohio State University, Columbus, Ohio, USA; 2 Department of Biomedical Informatics, Ohio State University, Columbus, Ohio, USA; 3 Division of Internal Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA; 4 University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA; 5 MedStar Washington Hospital Center, Washington, District of Columbia, USA; 6 Asian Institute of Gastroenterology, Hyderabad, Telangana, India; 7 Postgraduate Institute of Medical Education & Research, Chandigarh, Punjab, India; 8 Apollo Gleneagles Hospitals Kolkata, Kolkata, India; 9 Division of Gastroenterology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA; 10 Universidad Aut ónoma de Nueva Le ón, Monterrey, Mexico; 11 Division of Gastroenterology, Digestive Diseases Institute, Cleveland Clinic, Cleveland, Ohio, USA; 12 University of Medicine and Pharmacy "Iuliu Hatieganu," Cluj-Napoca, Romania; 13 Eastern Maine Medical Center, Bangor, Maine, USA; 14 Hospital Nacional "Profesor Alejandro Posadas", Buenos Aires, Argentina; 15 University of Medicine and Pharmacy, Bucharest, Romania; 16 San Raffaele Scientific Institute, Vita Salute San Raffaele University, Milan, Italy; 17 Indiana University School of Medicine, Indianapolis, Indiana, USA; 18 Attikon University General Hospital, Athens, Greece; 19 Hospital General de Agudos Dr. Cosme Argerich, Buenos Aires, Argentina; harmful effects of aggressive volume of intravenous fluid (IVF) has been shown in a recently published landmark randomized controlled trial (RCT), it remains unclear which type of IVF should be administered (i.e., lactated ringers [LR] vs normal saline) (4)(5)(6). A recent pilot RCT showed that high-volume (median 5,600 mL/24 hours) administration of LR in patients with mild AP results in faster clinical recovery (7).…”